Caleb C. McLeod, PharmD

home / authors / caleb-c-mcleod-pharmd

Caleb C. McLeod, PharmD, is a first-year infectious diseases pharmacotherapy fellow at Loma Linda University Medical Center in California. His interests include antimicrobial resistance and antimicrobial stewardship.

Articles

Cefiderocol’s Role in Managing Carbapenem-Resistant Acinetobacter baumannii Infections

Cefiderocol’s Role in Managing Carbapenem-Resistant Acinetobacter baumannii Infections

Caleb C. McLeod, PharmD;Jacinda C. Abdul-Mutakabbir, PharmD, MPH;Karen Tan, PharmD, BCIDP
July 20th 2022

This agent is likely best utilized as part of a combination when treating this bacterium but data regarding appropriate combinations are scarce.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Effects of Switching Antibiotics Mid-Treatment on Antimicrobial Resistance
Published: March 9th 2022 | Updated: December 22nd 2024
Effects of Switching Antibiotics Mid-Treatment on Antimicrobial Resistance
COVID-19 Therapy Roundtable: What is the Virus Today, Treatment Options, and Addressing the Pediatric Population
Published: December 5th 2024 | Updated: December 22nd 2024
COVID-19 Therapy Roundtable: What is the Virus Today, Treatment Options, and Addressing the Pediatric Population
COVID-19 Roundtable: Should Clinicians Consider Off Label COVID Therapies?
Published: December 19th 2024 | Updated: December 22nd 2024
COVID-19 Roundtable: Should Clinicians Consider Off Label COVID Therapies?
Peer-Assisted Telemedicine Enables More People With Hepatitis C to Get into the Continuum of Care
Published: December 17th 2024 | Updated: December 22nd 2024
Peer-Assisted Telemedicine Enables More People With Hepatitis C to Get into the Continuum of Care
Ethical and Innovative Use of AI in Infectious Disease
Published: December 18th 2024 | Updated: December 22nd 2024
Ethical and Innovative Use of AI in Infectious Disease
© 2024 MJH Life Sciences

All rights reserved.